Senators Put Largest U.S. Hospital Landlord Under Scrutiny In Bipartisan Probe

Lawmakers are scrutinizing Medical Properties Trust, asking whether its business model undermined healthcare offerings for patients.

Skanska To 'Postpone Future Growth' In U.S. Amid Office Market Challenges

The Swedish developer has new office projects under construction in the D.C., Seattle and Houston markets, but executives said it is seeing leasing challenges.

British Fund Giant Legal & General Buys Stake In Taurus To Deepen U.S. Multifamily Push

L&G first launched its U.S. asset management business in 2006 and now aims to expand its global private markets platform to $112B in AUM by 2028.

China's Largest Coffee Chain Plans Entry Into U.S. Markets

China's most popular coffee shop, Luckin Coffee, is looking to expand in America and continue its competition with Starbucks.

Lower Interest Rates And An Industrial Boom: Peter Linneman’s Predictions For The U.S. Economy

Peter Linneman is back on the Walker Webcast, discussing the future of the economy and what CRE should expect in 2024.

Greystar’s First U.S. Modular Apartment Complex Signals Growth In Once-Fringe Sector

Greystar's first modular apartment complex in Pennsylvania was built about 40% faster than comparable traditional construction projects.

TikTok Continues Its Real Estate Push Despite House Passing Bill To Ban It In U.S.

The social media giant is under threat in Congress, with hundreds of thousands of square feet of real estate hanging in the balance.

Wyndham Launches Extended-Stay Brand In U.S. With 5 Apartment-Style Hotels

The Wyndham Residences brand, in partnership with Reside, is launching with hotels in D.C., Houston, Seattle and New Orleans and has major expansion plans.

Rents Soar 20% In Largest U.S. Data Center Markets

A new report from CBRE shows how much data center tenants' rent prices and power costs are rising in major industry hubs.

Inside The Cell Therapeutics Plant Kicking Off AstraZeneca's $3.5B U.S. Push

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S. operations by the end of 2026.